Gene · 4154
Papers2,262
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,262
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Promoter-targeted small RNA duplexes increase MBNL1 transcription and mitigate myotonic dystrophy-associated spliceopathy. | Nucleic Acids Res | 2025 | 40829807 | PubTator, text mining | PubMed |
| Long-Term Neuroimaging Findings in a Murine Model of Human Extraparenchymal Neurocysticercosis. | ACS Infect Dis | 2025 | 40825018 | PubTator, text mining | PubMed |
| NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancer. | Front Immunol | 2025 | 40821787 | PubTator, text mining | PubMed |
| Transcriptome alterations underlying metabolic dysfunction and liver disease in myotonic dystrophy type 1. | Hum Mol Genet | 2025 | 40801161 | PubTator, text mining | PubMed |
| Decoding circRNA translation: challenges and advances in computational method development. | Front Genet | 2025 | 40799216 | PubTator, text mining | PubMed |
| New insights into the dule roles CDK12 in human cancers: Mechanisms and interventions for cancer therapy. | J Pharm Anal | 2025 | 40747342 | PubTator, text mining | PubMed |
| Enhanced genetic fine mapping accuracy with Bayesian Linear Regression models in diverse genetic architectures. | PLoS Genet | 2025 | 40737338 | PubTator, text mining | PubMed |
| Quantitative evaluation of methods to analyze motion changes in single-particle experiments. | Nat Commun | 2025 | 40695819 | PubTator, text mining | PubMed |
| The situatedness of instructional quality-How situated are college students' ratings? | Br J Educ Psychol | 2025 | 40625084 | PubTator, text mining | PubMed |
| Ring-finger protein RNF126 promotes prostate cancer progression via regulation of MBNL1. | Sci Rep | 2025 | 40615482 | PubTator, text mining | PubMed |
| Repeat length as a key determinant for disease severity and antisense oligonucleotide activity in myotonic dystrophy type 1. | Mol Ther Methods Clin Dev | 2025 | 40606545 | PubTator, text mining | PubMed |
| Comparative Analysis of MBNL1 Antibodies: Characterization of Recognition Sites and Detection of RNA Foci Colocalization. | Genes (Basel) | 2025 | 40565550 | PubTator, text mining | PubMed |
| Identification of Splicing Regulatory Activity of ATXN1 and Its Associated Domains. | Biomolecules | 2025 | 40563422 | PubTator, text mining | PubMed |
| Shared Genetic Characteristics of Coronary Artery Disease and Peripheral artery Disease: Insights From Integrated Bioinformatics Analysis of RNA-Sequencing Data. | Bioinform Biol Insights | 2025 | 40535026 | PubTator, text mining | PubMed |
| Exosome-derived lnc-FAM72D-3 promotes lenvatinib resistance by remodeling hepatocellular carcinoma cytoskeleton via MBNL1/FAK axis. | Drug Resist Updat | 2025 | 40517686 | PubTator, text mining | PubMed |
| Genetic and Microbial Analysis of Invasiveness for Escherichia coli Strains Associated With Inflammatory Bowel Disease. | Cell Mol Gastroenterol Hepatol | 2025 | 40437706 | PubTator, text mining | PubMed |
| RNA‑binding protein MBNL1 regulates tumor growth, chemosensitivity and antitumor immunity in lung adenocarcinoma by controlling the expression of tumor suppressor RNF125. | Oncol Rep | 2025 | 40341413 | PubTator, text mining | PubMed |
| Muscleblind-like proteins are novel modulators of the tumor-immune microenvironment. | PLoS One | 2025 | 40305509 | PubTator, text mining | PubMed |
| Comprehensive analysis of splicing variants in corneal endothelial cells of patients with Fuchs endothelial corneal dystrophy. | Sci Rep | 2025 | 40287469 | PubTator, text mining | PubMed |
| DM1 repeat-expanded RNAs confer RNA toxicity as individual nuclear-retained RNAs. | Cell Rep | 2025 | 40238630 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4154/papers?page=4